The Latest Cardiac and Vascular News
Dr. Donohoe brings nearly 30 years of successful clinical and regulatory experience advancing medical devices in the cardiology and endovascular space NEW HOPE, Pa., Aug. 27, 2019 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs in […]
REDWOOD CITY, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD) today announced the closing of an underwritten public offering of 3,813,559 shares of its common stock at a price of $1.18 per share, for total gross proceeds […]
Expands Solutions for Cardiac Arrest Victims in the Community CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today confirmed that it has completed the previously announced acquisition of Cardiac Science® Corporation, a leading provider of automated external defibrillators (AEDs), related […]
SUNNYVALE, Calif., Aug. 27, 2019 /PRNewswire/ — EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced it has closed $30M in new funding to complete enrollment of its pivotal SOLVE CRT clinical trial and to prepare for commercialization of the WiSE Cardiac Resynchronization Therapy (CRT) System. This […]
REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced that it intends to offer shares of its common stock for sale in an underwritten public offering. In addition, the Company expects to grant […]
VANCOUVER, Aug. 22, 2019 /PRNewswire/ – (“Neovasc” or the “Company”) (NASDAQ:NVCN)(TSX:NVCN), announced today that it has received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum market value requirement set forth in Nasdaq Rules for continued listing on […]
WINNIPEG, Aug. 21, 2019 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, today announces that its subsidiary, Medicure International Inc., has settled its ongoing patent infringement action against Gland Pharma Ltd. (“Gland”) in the U.S. District Court for the District of New Jersey, which alleged infringement of […]
SAN CARLOS, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results and business highlights for the second quarter 2019 and filed its quarterly report on Form 10-Q for the three and six months ended […]
UH Cleveland Medical Center welcomes Dr. Marc Pelletier Marc Pelletier, MD, MSc, FRCSC, has joined University Hospitals as Chief, Division of Cardiac Surgery, UH Cleveland Medical Center and Director, Heart Surgery Center, UH Harrington Heart & Vascular Institute. Dr. Pelletier joins UH from Brigham and Women’s Hospital […]
Revenue of $7.5 Billion Increased 1.5% Reported; Increased 3.5% Constant Currency GAAP Diluted EPS of $0.64; Non-GAAP Diluted EPS of $1.26 Company Raises FY20 EPS Guidance by 10 Cents DUBLIN, Aug. 20, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year […]
